MedTrace Logo

Prospective, In-Vivo, Post-Market Safety and Efficacy Surveillance Registry of the MAXX Orthopedics, Freedom Total Knee® System

NCT06627699 · Status: NOT_YET_RECRUITING · Type: OBSERVATIONAL · Enrollment: 300

Last updated 2024-10-04

No results posted yet for this study

Summary

In an effort to satisfy regulatory requirements for post-market surveillance of product safety and efficacy, a representative sample of patients will be recruited for prospective monitoring.

Conditions

  • Knee Osteoarthristis
  • Total Knee Anthroplasty

Interventions

DEVICE

Total Knee Arthroplasty

Post-Market Surveillance of the Freedom Total Knee System for Primary TKA

Sponsors & Collaborators

  • Maxx Orthopedics Inc

    lead INDUSTRY

Principal Investigators

  • Asit Shah, MD, PhD · Chief of Orthopedics, Englewood Hospital

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-11-01
Primary Completion
2027-11-01
Completion
2028-03-01

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06627699 on ClinicalTrials.gov